Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05625958 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery

Study acronym: SAFARI4
StatusActive, Not Recruiting
PhaseNot applicable
SponsorCiliatech
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 22, 2026 (before its estimated April 29, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 6 to 5
    • Primary completion date: Mar 1, 2026 to Apr 29, 2026
    v5
  2. Trial status: Not Yet Recruiting to Recruitingv4 Show 8 more changesShow less
    • Primary completion date: Oct 1, 2023 to Mar 1, 2026
    • Enrollment target: 35 to 29
    • Study sites: 0 to 6
    • Study completion date: Jun 1, 2026 to Sep 1, 2028
    • Start date changed from estimate of Mar 1, 2023 to Mar 23, 2023
    • Eligibility criteria expanded, about 788 words
    • Secondary endpoints expanded, about 174 words
    • Study description revised
  3. Eligibility criteria revisedv3
  4. Study title shortened, about 2 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ciliatech
2 trials monitored
See all monitored trials
The purpose of this study is to evaluate the safety and effectiveness of implanting a new version of an interposition supraciliary implant (SV22) as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open and narrow angle glaucoma who have failed at least one class of topical medical therapy
Trial Details
NCT Number NCT05625958
Lead Sponsor Ciliatech
Conditions
(from sponsor)		 Glaucoma, Open-Angle, Glaucoma, Narrow Angle
Related terms Glaucoma, Angle-Closure, Glaucoma, Open-Angle
Enrollment 29 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov